4.7 Article

The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes

Journal

NATURE IMMUNOLOGY
Volume 15, Issue 7, Pages 623-630

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2889

Keywords

-

Categories

Funding

  1. Medical Research Council [G0802838, G9818340]
  2. European Union Marie Curie Actions
  3. Wellcome Trust [WT090962MA]
  4. European Research Council [322645]
  5. Deutsche Forschungsgemeinschaft [SFB738-B5, EXC62]
  6. Boehringer Ingelheim Fonds
  7. MRC [G0802838, G9818340, G0901113] Funding Source: UKRI
  8. European Research Council (ERC) [322645] Funding Source: European Research Council (ERC)
  9. Medical Research Council [G0901113, G0802838, G9818340] Funding Source: researchfish

Ask authors/readers for more resources

Afferent lymph borne dendritic cells essentially rely on the chemokine receptor CCR7 for their transition from the subcapsular lymph node sinus into the parenchyma, a migratory step driven by putative gradients of CCR7 ligands. We found that lymph node fringes indeed contained physiological gradients of the chemokine CCL21, which depended on the expression of CCRL1, the atypical receptor for the CCR7 ligands CCL19 and CCL21. Lymphatic endothelial cells lining the ceiling of the subcapsular sinus, but not those lining the floor, expressed CCRL1, which scavenged chemokines from the sinus lumen. This created chemokine gradients across the sinus floor and enabled the emigration of dendritic cells. In vitro live imaging revealed that spatially confined expression of CCRL1 was necessary and sufficient for the creation of functional chemokine gradients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available